Predictors of response to venetoclax plus hypomethylating agent therapy and survival in blastphase myeloproliferative neoplasm

• Naseema Gangat,
• Rimal Ilyas,
• Kristen McCullough,
• Kebede H. Begna,
• Aref Al-Kali,
• Mrinal M. Patnaik,
• Mark R. Litzow,
• William J. Hogan,
• Abhishek Mangaonkar,
• Hassan Alkhateeb,
• Mithun V. Shah,
• Michelle A. Elliott,
• James M. Foran,
• Talha Badar,
• Jeanne M. Palmer,
• Curtis A. Hanson,
• Animesh Pardanani,
• Ayalew Tefferi

Affiliations

Naseema Gangat

Division of Hematology, Mayo Clinic, Rochester, MN

Rimal Ilyas

Division of Hematology, Mayo Clinic, Rochester, MN

Kristen McCullough

Division of Hematology, Mayo Clinic, Rochester, MN

Kebede H. Begna

Division of Hematology, Mayo Clinic, Rochester, MN

Aref Al-Kali

Division of Hematology, Mayo Clinic, Rochester, MN

Mrinal M. Patnaik

Division of Hematology, Mayo Clinic, Rochester, MN

Mark R. Litzow

Division of Hematology, Mayo Clinic, Rochester, MN

William J. Hogan

Division of Hematology, Mayo Clinic, Rochester, MN

Abhishek Mangaonkar

Division of Hematology, Mayo Clinic, Rochester, MN

Hassan Alkhateeb

Division of Hematology, Mayo Clinic, Rochester, MN

Mithun V. Shah

Division of Hematology, Mayo Clinic, Rochester, MN

Michelle A. Elliott

Division of Hematology, Mayo Clinic, Rochester, MN

James M. Foran

Division of Hematology, Mayo Clinic, Jacksonville FL

Talha Badar

Division of Hematology, Mayo Clinic, Jacksonville FL

Jeanne M. Palmer

Division of Hematology, Mayo Clinic, Scottsdale, AZ

Curtis A. Hanson

Division of Hematopathology, Mayo Clinic, Rochester, MN

Animesh Pardanani

Division of Hematology, Mayo Clinic, Rochester, MN

Ayalew Tefferi

Division of Hematology, Mayo Clinic, Rochester, MN